Tenet Healthcare Corporation (NYSE:THC) Given Average Rating of “Moderate Buy” by Analysts

Shares of Tenet Healthcare Corporation (NYSE:THC) have been given an average recommendation of “Moderate Buy” by the twenty-two ratings firms that are currently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $244.3158.

Several research analysts have issued reports on the company. KeyCorp dropped their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Mizuho increased their target price on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research report on Thursday, March 12th. Guggenheim reduced their price target on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Weiss Ratings lowered shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Finally, Royal Bank Of Canada reduced their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st.

Tenet Healthcare Stock Up 6.8%

Shares of THC stock opened at $204.28 on Friday. The stock has a market cap of $17.60 billion, a P/E ratio of 10.62, a price-to-earnings-growth ratio of 1.57 and a beta of 1.27. The stock has a fifty day moving average price of $181.22 and a 200 day moving average price of $197.26. Tenet Healthcare has a one year low of $146.60 and a one year high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Analysts predict that Tenet Healthcare will post 17.61 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.97% of the stock is currently owned by insiders.

Institutional Trading of Tenet Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Triumph Capital Management acquired a new position in Tenet Healthcare during the 3rd quarter worth $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the fourth quarter worth $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare during the fourth quarter valued at $29,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter valued at about $35,000. Finally, Meeder Asset Management Inc. raised its holdings in Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.